A New Model to Predict Survival in Patients with Refractory Celiac Disease (MRCD): Results from a Multinational Study
Alberto Rubio‐Tapia(Cleveland Clinic), Christophe Cellier(Assistance Publique – Hôpitaux de Paris), Wieke H.M. Verbeek(Vrije Universiteit Amsterdam), Brian D. Lahr(Mayo Clinic), Daniel A. Leffler(Beth Israel Deaconess Medical Center), Peter Green(AgResearch), Chris J. Mulder(Amsterdam University Medical Centers), Georgia Malamut(Délégation Paris 5), Sonia I. Niveloni(Instituto de Gastroenterología), Joseph A. Murray(Johns Hopkins University), Ciarán P. Kelly(Met Éireann), Carolina Argüelles-Grande(Columbia University Irving Medical Center), Julio C. Bai(Universidad del Salvador), S Daum(Klinik und Poliklinik für Urologie, Kinderurologie und Andrologie)
Cited by 0
Related Papers
Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)
|Clinical Infectious Diseases|2017|2.7k
Global Prevalence of Celiac Disease: Systematic Review and Meta-analysis
|Clinical Gastroenterology and Hepatology|2018|1.7k
Spectrum of gluten-related disorders: consensus on new nomenclature and classification
|BMC Medicine|2012|1.1k